Accredited Investors Inc. Takes $240,000 Position in Waters Co. (WAT)

Share on StockTwits

Accredited Investors Inc. bought a new position in shares of Waters Co. (NYSE:WAT) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 953 shares of the medical instruments supplier’s stock, valued at approximately $240,000.

Other institutional investors have also recently bought and sold shares of the company. Athena Capital Advisors LLC purchased a new position in Waters in the 4th quarter valued at approximately $28,000. Rockland Trust Co. purchased a new position in Waters in the 4th quarter valued at approximately $38,000. Reilly Financial Advisors LLC grew its stake in Waters by 334.8% in the 4th quarter. Reilly Financial Advisors LLC now owns 200 shares of the medical instruments supplier’s stock valued at $38,000 after buying an additional 154 shares in the last quarter. Lindbrook Capital LLC purchased a new position in Waters in the 4th quarter valued at approximately $41,000. Finally, Massey Quick Simon & CO. LLC purchased a new position in Waters in the 1st quarter valued at approximately $43,000. 95.90% of the stock is currently owned by hedge funds and other institutional investors.

In related news, SVP Terrence P. Kelly sold 2,942 shares of the company’s stock in a transaction on Monday, January 28th. The shares were sold at an average price of $228.95, for a total value of $673,570.90. Following the completion of the transaction, the senior vice president now directly owns 4,888 shares in the company, valued at $1,119,107.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Mark T. Beaudouin sold 27,848 shares of the company’s stock in a transaction on Friday, January 25th. The stock was sold at an average price of $225.36, for a total transaction of $6,275,825.28. Following the completion of the transaction, the senior vice president now owns 2,796 shares of the company’s stock, valued at $630,106.56. The disclosure for this sale can be found here. Insiders sold 105,032 shares of company stock valued at $24,284,760 over the last quarter. 0.98% of the stock is owned by company insiders.

A number of research analysts recently weighed in on the stock. Zacks Investment Research lowered shares of Waters from a “strong-buy” rating to a “hold” rating in a research note on Friday, April 12th. Barclays reiterated a “hold” rating and issued a $200.00 price objective on shares of Waters in a research note on Friday, January 25th. BTIG Research lifted their price objective on shares of Waters to $260.00 and gave the company a “buy” rating in a research note on Thursday, January 24th. Robert W. Baird lowered shares of Waters from an “outperform” rating to a “neutral” rating and boosted their price target for the company from $191.00 to $211.00 in a research report on Thursday, January 24th. Finally, TheStreet upgraded shares of Waters from a “c+” rating to a “b” rating in a research report on Thursday, January 17th. Two investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have issued a buy rating to the company’s stock. Waters has an average rating of “Hold” and an average price target of $208.99.

Shares of WAT traded down $1.01 during mid-day trading on Wednesday, reaching $239.70. 8,141 shares of the stock traded hands, compared to its average volume of 420,428. The firm has a market capitalization of $17.61 billion, a P/E ratio of 29.13, a price-to-earnings-growth ratio of 2.46 and a beta of 1.19. The company has a debt-to-equity ratio of 0.73, a current ratio of 5.93 and a quick ratio of 5.28. Waters Co. has a 1 year low of $167.93 and a 1 year high of $255.21.

Waters (NYSE:WAT) last announced its earnings results on Wednesday, January 23rd. The medical instruments supplier reported $2.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.64 by $0.23. Waters had a net margin of 24.54% and a return on equity of 34.18%. The company had revenue of $715.00 million during the quarter, compared to analyst estimates of $702.74 million. During the same period in the previous year, the business earned $2.51 earnings per share. The firm’s quarterly revenue was up 4.0% compared to the same quarter last year. On average, analysts expect that Waters Co. will post 9.35 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “Accredited Investors Inc. Takes $240,000 Position in Waters Co. (WAT)” was first published by Fairfield Current and is the sole property of of Fairfield Current. If you are viewing this story on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright legislation. The original version of this story can be accessed at https://www.fairfieldcurrent.com/news/2019/04/17/accredited-investors-inc-takes-240000-position-in-waters-co-wat.html.

Waters Company Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Read More: Green Investing

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply